Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Blood Collection of Trumenba in Healthy Adults
NCT00780806Phase 2Completed
- Sponsor
- Pfizer
- Start
- Oct 2008
- Primary completion
- May 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of meningococcal group B vaccine in meningococcal group B infection (MenB), sponsored by Pfizer. Started Oct 2008; status: completed.
02
Drugs
meningococcal group B vaccine
03
Conditions
meningococcal group B infection (MenB)
Beyond the preview
Go deeper on NCT00780806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00780806.